SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-09-007034
Filing Date
2009-02-06
Accepted
2009-02-06 08:30:48
Documents
11
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q a09-3991_110q.htm 10-Q 737366
2 EX-10.1 a09-3991_1ex10d1.htm EX-10.1 53426
3 EX-10.2 a09-3991_1ex10d2.htm EX-10.2 52739
4 EX-10.3 a09-3991_1ex10d3.htm EX-10.3 54245
5 EX-10.4 a09-3991_1ex10d4.htm EX-10.4 54140
6 EX-10.5 a09-3991_1ex10d5.htm EX-10.5 53999
7 EX-10.6 a09-3991_1ex10d6.htm EX-10.6 16098
8 EX-10.7 a09-3991_1ex10d7.htm EX-10.7 73473
9 EX-31.1 a09-3991_1ex31d1.htm EX-31.1 12666
10 EX-31.2 a09-3991_1ex31d2.htm EX-31.2 12524
11 EX-32 a09-3991_1ex32.htm EX-32 9613
  Complete submission text file 0001104659-09-007034.txt   1131651
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
IMMUNOGEN INC (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-17999 | Film No.: 09574716
SIC: 2834 Pharmaceutical Preparations